Public companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last week [Yahoo! Finance]
Gyre Therapeutics, Inc. (GYRE)
Company Research
Source: Yahoo! Finance
The largest shareholder of the company is GNI Group Ltd. with a 75% stake Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock A look at the shareholders of Gyre Therapeutics, Inc. ( NASDAQ:GYRE ) can tell us which group is most powerful. With 75% stake, public companies possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk). Clearly, public companies benefitted the most after the company's market cap rose by US$137m last week. Let's take a closer look to see what the different types of shareholders can tell us about Gyre Therapeutics. See our latest analysis for Gyre Therapeutics What Does The Lack Of Institutional Ownership Tell Us About Gyre Therapeutics? Small companies that are not very actively traded often lack institutional investors, but it's less common to see large companies without them. There could be various reasons wh
Show less
Read more
Impact Snapshot
Event Time:
GYRE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GYRE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GYRE alerts
High impacting Gyre Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
GYRE
News
- Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
- Gyre Therapeutics: Under The Radar Biotech Has A Shot At MASH Approval, In Time [Seeking Alpha]Seeking Alpha
- Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateGlobeNewswire
GYRE
Sec Filings
- 5/13/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 5/8/24 - Form 8-K
- GYRE's page on the SEC website